financetom
Business
financetom
/
Business
/
CRA International CFO Daniel Mahoney to Depart
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CRA International CFO Daniel Mahoney to Depart
Mar 13, 2025 3:07 PM

05:54 PM EDT, 03/13/2025 (MT Newswires) -- Charles River Associates (CRAI) said Thursday that Chief Financial Officer Daniel Mahoney is leaving for a new role outside the consulting industry, effective April 11.

Chief Corporate Development Officer and former CFO Chad Holmes will serve as interim CFO while the company searches for a replacement, according to CRA International ( CRAI ).

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
New Gold Accepts Over $288 Million of 2027 Notes in Tender Offer
New Gold Accepts Over $288 Million of 2027 Notes in Tender Offer
Mar 14, 2025
07:15 AM EDT, 03/14/2025 (MT Newswires) -- New Gold ( NGD ) said Friday that holders submitted roughly $288.8 million worth of its 7.5% notes due 2027 by the March 13 deadline. The company said this amount accounts for just over 72% of the $400 million total, excluding those filed under guaranteed delivery procedures. All valid submissions are expected to...
BMO on The Day Ahead in Canada
BMO on The Day Ahead in Canada
Mar 14, 2025
07:21 AM EDT, 03/14/2025 (MT Newswires) -- On the data docket for Canada at 8:30 a.m. ET Friday are manufacturers' shipments and wholesale trade both for January, said Bank of Montreal (BMO). They are expected to spike around 2% month over month in January, partly in anticipation of United States tariffs, noted the bank. New motor vehicle sales look to...
Buckle's Fiscal Q4 Earnings, Net Sales Fall
Buckle's Fiscal Q4 Earnings, Net Sales Fall
Mar 14, 2025
07:13 AM EDT, 03/14/2025 (MT Newswires) -- Buckle (BKE) reported fiscal Q4 earnings Friday of $1.53 per diluted share, down from $1.59 a year earlier. Two analysts polled by FactSet expected $1.39. Net sales for the quarter ended Feb. 1 were $379.2 million, down from $382.4 million a year earlier. Two analysts surveyed by FactSet expected $373.7 million. Buckle's stock...
Eton's Diabetes Drug Candidate Passes Bioequivalence Study
Eton's Diabetes Drug Candidate Passes Bioequivalence Study
Mar 14, 2025
07:20 AM EDT, 03/14/2025 (MT Newswires) -- Eton Pharmaceuticals ( ETON ) said Friday a bioequivalence study of its product candidate ET-600 showed pharmacokinetic equivalence to the U.S. Food and Drug Administration (FDA)-approved reference product of the same active ingredient. ET-600 is an oral solution of desmopressin under development for the treatment of central diabetes insipidus. Eton said it expects...
Copyright 2023-2026 - www.financetom.com All Rights Reserved